Interestingly, a recent publication demonstrated tumor heterogeneity in two CCRCC tumors where one tumor from a male patient had the same VHL and PBRM1 mutations in all regions but had gained different KDM5C mutations in different tumor regions demonstrating the repeated importance of losing expression of this gene [8]. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.